SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hongbin Wang, Li Wei, Changli Li, Jing Zhou, Zhigao Li, CDK5RAP1 deficiency induces cell cycle arrest and apoptosis in human breast cancer cell line by the ROS/JNK signaling pathway, Oncology Reports, 2015,

    CrossRef

  2. 2
    Wendy A. Cooper, Thang Tran, Ricardo E. Vilain, Jason Madore, Christina I. Selinger, Maija Kohonen-Corish, PoYee Yip, Bing Yu, Sandra A. O’Toole, Brian C. McCaughan, Jennifer H. Yearley, Lisa G. Horvath, Steven Kao, Michael Boyer, Richard A. Scolyer, PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma, Lung Cancer, 2015, 89, 2, 181

    CrossRef

  3. 3
    Zheng-hua Fei, Kan Wu, Yun-liang Chen, Bing Wang, Shi-rong Zhang, Sheng-lin Ma, Capilliposide Isolated fromLysimachia capillipesHemsl. Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Human Nonsmall Cell Lung Cancer Cell Lines, Evidence-Based Complementary and Alternative Medicine, 2014, 2014, 1

    CrossRef

  4. 4
    U Bertsch, C Röder, H Kalthoff, A Trauzold, Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2, Cell Death and Disease, 2014, 5, 8, e1390

    CrossRef

  5. 5
    Jin Fan, Zitao Zhang, Xie Chao, Jun Gu, Weihua Cai, Wei Zhou, Guoyong Yin, Qingqing Li, Ischemic preconditioning enhances autophagy but suppresses autophagic cell death in rat spinal neurons following ischemia-reperfusion, Brain Research, 2014, 1562, 76

    CrossRef

  6. 6
    P. Y. Yip, W. A. Cooper, M. R. J. Kohonen-Corish, B. P. C. Lin, B. C. McCaughan, M. J. Boyer, J. G. Kench, L. G. Horvath, Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer, Journal of Clinical Pathology, 2014, 67, 4, 333

    CrossRef

  7. 7
    Martin Reck, Maciej Krzakowski, Ewa Chmielowska, Martin Sebastian, Dietrich Hadler, Tara Fox, Qiang Wang, Jon Greenberg, Robert A. Beckman, Joachim von Pawel, A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer, Lung Cancer, 2013, 82, 3, 441

    CrossRef

  8. You have free access to this content8
    O Micheau, S Shirley, F Dufour, Death receptors as targets in cancer, British Journal of Pharmacology, 2013, 169, 8
  9. 9
    Lei Jiang, Jin-Li Hao, Mu-Lan Jin, Yun-Gang Zhang, Ping Wei, Effect of Embelin on TRAIL Receptor 2 mAb-induced Apoptosis of TRAIL-resistant A549 Non-small Cell Lung Cancer Cells, Asian Pacific Journal of Cancer Prevention, 2013, 14, 10, 6115

    CrossRef

  10. 10
    R. Pare, T. Yang, J.-S. Shin, C. S. Lee, The significance of the senescence pathway in breast cancer progression, Journal of Clinical Pathology, 2013, 66, 6, 491

    CrossRef

  11. 11
    L. Guilleminault, E. Lemarié, N. Heuzé-Vourc’h, Monoclonal Antibodies: An Emerging Class of Therapeutics in Non Small Cell Lung Cancer, Journal of Cancer Therapy, 2012, 03, 06, 1170

    CrossRef

  12. 12
    Changxia Shao, Chuanwen Lu, Lixia Chen, Patrick P. Koty, Everardo Cobos, Weimin Gao, p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma, Cancer Chemotherapy and Pharmacology, 2011, 67, 6, 1369

    CrossRef

  13. 13
    T R Wilson, K M Redmond, K M McLaughlin, N Crawford, K Gately, K O'Byrne, C Le-Clorrenec, C Holohan, D A Fennell, P G Johnston, D B Longley, Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing, Cell Death and Differentiation, 2009, 16, 10, 1352

    CrossRef